Stay updated on PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial
Sign up to get notified when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.

Latest updates to the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page
- Check3 days agoChange DetectedPage revision updated from v3.6.0 to v3.6.2, indicating a minor backend/template update. This change does not modify study details, eligibility criteria, or results shown on the page.SummaryDifference0.0%

- Check10 days agoNo Change Detected
- Check17 days agoChange DetectedNew help and navigation sections were added (How to Read a Study Record, Common Questions, How to Join a Study) and metadata labels (Last verified, Last known status was) were introduced. A site revision update (Revision: v3.6.0) and a minor formatting change to the Intervention/Treatment heading were also applied.SummaryDifference1%

- Check25 days agoChange DetectedThe page's revision tag was updated from v3.5.4 to v3.5.5, reflecting a newer metadata version of the study page.SummaryDifference0.0%

- Check46 days agoChange DetectedThe page revision has been updated from v3.5.3 to v3.5.4, indicating a metadata change on the page rather than a modification of the study details. The core content of the page remains unchanged.SummaryDifference0.0%

- Check61 days agoChange DetectedThe page now displays a new revision tag: Revision: v3.5.3, indicating a minor update to the record.SummaryDifference0.0%

- Check75 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing the previous Revision: v3.5.0.SummaryDifference0.0%

Stay in the know with updates to PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the PEOPLE: Pembrolizumab in Low PD-L1 NSCLC Clinical Trial page.